Health
Pfizer, BioNTech to supply 120 million doses of coronavirus vaccine to Japan – Reuters India
Pfizer Inc and BioNTech SE have agreed to supply Japan with 120 million doses of their experimental coronavirus vaccine in the first half of 2021, the companies said on Friday.

(Reuters) – Pfizer Inc (PFE.N) and BioNTech SE (BNTX.O) have agreed to supply Japan with 120 million doses of their experimental coronavirus vaccine in the first half of 2021, the companies said on Friday.
The companies did not disclose the financial details of the agreement, but said terms were based on the volume of doses and the timing of the delivery.
The United States has signed a similar deal with Pfizer and BioNtech for 100 million doses for nearly $2 billion, which amounts to a $39 p…
-
General22 hours ago
Australian celebrity chef Peter Russell-Clarke dies aged 89
-
General23 hours ago
Lithium mine closure shines light on Ravensthorpe community’s resilience
-
Noosa News21 hours ago
Woman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
General24 hours ago
Back-to-back rate cuts tipped when Reserve Bank meets